GLUTAFERRO 170 mg/ml ORAL SOLUTION DROPS
Ask a doctor about a prescription for GLUTAFERRO 170 mg/ml ORAL SOLUTION DROPS
How to use GLUTAFERRO 170 mg/ml ORAL SOLUTION DROPS
Introduction
Package Leaflet: Information for the User
GLUTAFERRO170 mg/ml oral drops in solution
(Ferroglycine sulfate)
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
|
Contents of the package leaflet:
- What is Glutaferro and what is it used for
- What you need to know before you take Glutaferro
- How to take Glutaferro
- Possible side effects
- Storage of Glutaferro
- Contents of the pack and further information
1. What is Glutaferro and what is it used for
Glutaferro is presented as oral drops in solution.
This medicinal product belongs to the group of medicinal products called iron supplements.
Glutaferro is used for the treatment of iron deficiency conditions.
2. What you need to know before you take Glutaferro
Do not take Glutaferro
- If you are allergic to ferroglycine sulfate or any of the other ingredients of this medicinal product (listed in section 6).
- If you have esophageal stenosis (narrowing) due to any type of gastrointestinal disorder.
- If you have iron overload (increased amount of iron in the blood).
Warnings and precautions
Consult your doctor, pharmacist, or nurse before taking this medicinal product.
Iron preparations can cause poisoning, especially in children.
This medicinal product should be administered with caution.
- If you are taking another iron supplement in your diet and/or iron salts.
- If you have any of these diseases: hemolytic anemia, hemoglobinopathies (blood diseases that alter oxygen transport), myelodysplasia (inadequate functioning of the bone marrow) or alterations in iron absorption or storage.
Other medicines and Glutaferro
Use of Glutaferro with other medicines. Inform your doctor or pharmacist if you are using, have recently used, or might use any other medicines.
The effect of treatment may be affected if Glutaferro is administered simultaneously with other medicines.
Intravenous administration of iron salts and doxycycline should be avoided.
Glutaferro should not be administered until at least two to four hours after the administration of any of the following therapeutic agents:
- Antacids: the therapeutic effect of Glutaferro may be impaired if administered concomitantly with antacids. The minimum time interval between the administration of antacids and iron is two hours.
- Thyroid hormones: Glutaferro decreases the effect of medicines containing thyroid hormones if administered concomitantly. The minimum time interval between the administration of thyroid hormones and iron is two hours.
- Anti-infectious medicines: Glutaferro decreases the effect of certain anti-infectious medicines (tetracyclines and fluoroquinolones) if administered simultaneously. In the case of fluoroquinolones, they should be administered at least two hours before or four hours after Glutaferro. In the case of tetracyclines other than doxycycline, the interval between administration should be at least three hours.
- Other medicines: other medicines may be affected by treatment with Glutaferro: methyldopa (administer with the widest possible interval), penicillamine (administer at least two hours before Glutaferro), bisphosphonates (administer with an interval of at least two hours), levodopa (administer with the widest possible interval), or non-steroidal anti-inflammatory drugs (may increase the irritating effect on the gastric mucosa of these drugs).
Use of Glutaferro with food, beverages, and alcohol
It is advisable to take the medicine at least 2 hours away from meals, as absorption may be reduced. Do not take the medicine with food, vegetable foods, milk or derivatives, coffee, tea, or beverages containing calcium. Iron absorption is decreased with calcium and with other agents present in certain foods that form complexes with iron.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking any medicine.
No known risks have been described with iron intake during pregnancy and breastfeeding.
Driving and using machines
No effects of this medicine on the ability to drive or use machines have been observed.
Glutaferro contains sorbitol.
This medicinal product contains 300 mg of sorbitol per ml.
Sorbitol is a source of fructose. If your doctor has told you that you (or your child) have an intolerance to some sugars, or have been diagnosed with hereditary fructose intolerance (HFI), a rare genetic disease in which the patient cannot break down fructose, consult your doctor before taking this medicine.
Glutaferro contains sodium
This medicinal product contains less than 23 mg of sodium (1 mmol) per daily dose, which is essentially "sodium-free".
3. How to take Glutaferro
Follow exactly the administration instructions of this medicinal product given by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.
Iron salts should be taken between meals for maximum absorption. If gastrointestinal side effects are observed, they should be administered during or after meals. In the case of children, Glutaferro can be administered mixed with water, juices, and even milk.
The recommended dose in adults is 1.5-2.5 ml three times a day.
Use in children and adolescents:
Up to 1 year and premature: ………….. 0.3-0.5 ml per day distributed with food.
From 1 to 6 years: …………………………. 0.2-0.7 ml three times a day.
Over 6 years: ………………….. 0.7 ml three times a day.
Treatment should continue until normal iron values are reached in the blood or until body iron reserves are restored.
If you experience side effects, consult your doctor. If you think the action of Glutaferro is too strong or too weak, tell your doctor or pharmacist.
If you take more Glutaferro than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist or call the Toxicology Information Service. Telephone 91 562.04.20 indicating the medicine and the amount ingested. Bring the package leaflet with you.
If you forget to take Glutaferro
Do not take a double dose to make up for forgotten doses.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
During the administration of Glutaferro, the following adverse reactions may occur:
Abdominal discomfort, heartburn, vomiting, diarrhea, constipation, dark stools, and exanthema (temporary skin rash).
These adverse reactions appear very rarely (affect less than 1 in 10,000 people).
Reporting of side effects
If you experience side effects, consult your doctor, pharmacist, or nurse, even if it is a possible side effect not listed in this leaflet. You can also report them directly through the Spanish Medicines and Healthcare Products Agency (AEMPS) https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
5. Storage of Glutaferro
Keep this medicinal product out of the sight and reach of children.
This medicinal product does not require any special storage temperature.
Expiry date:
Do not use this medicinal product after the expiry date stated on the packaging after - EXP. The expiry date is the last day of the month indicated.
Do not use this medicinal product if you notice that the packaging or closure is damaged.
Medicines should not be disposed of via wastewater or household waste. Place the packaging and medicines you no longer need in the pharmacy's SIGRE point. Ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.
6. Contents of the pack and further information
Composition of Glutaferro
The active substance of this medicinal product is ferroglycine sulfate 170 mg equivalent to 30 mg of Iron(II).
The other ingredients (excipients) are: sorbitol (E-420), sodium saccharin, orange essence, caramel. See section 2.
Appearance of the product and pack contents
Glutaferro is presented as oral drops in solution in packs containing 25 ml of solution and a dosing dropper.
Marketing authorization holder
MEDIX, S.A.
Calle del Plástico, nº 5 nave 9
Polígono Industrial Miralcampo
19200 Azuqueca de Henares (Guadalajara)
Manufacturer
INDUSTRIA QUIMICA Y FARMACEUTICA VIR, S.A.
C/La Laguna 66-68-70, Polígono Industrial Urtinsa II Alcorcón, 28923 (Madrid)
This leaflet was last revised in 07/2021
Detailed and updated information on this medicinal product is available on the website of the Spanish Agency for Medicines and Healthcare Products (AEMPS) http://www.aemps.es/
- Country of registration
- Active substance
- Prescription requiredYes
- Manufacturer
- This information is for reference only and does not constitute medical advice. Always consult a licensed doctor before taking any medication. Oladoctor is not responsible for medical decisions based on this content.
- Alternatives to GLUTAFERRO 170 mg/ml ORAL SOLUTION DROPSDosage form: CAPSULE, 100 mg ferrous glycinate sulfateActive substance: ferrous glycine sulfateManufacturer: Ucb Pharma S.A.Prescription requiredDosage form: CAPSULE, 100 mgActive substance: ferrous glycine sulfateManufacturer: Ucb Pharma S.A.Prescription requiredDosage form: MODIFIED-RELEASE TABLET, 105 mgActive substance: ferrous sulfateManufacturer: Teofarma S.R.L.Prescription required
Alternatives to GLUTAFERRO 170 mg/ml ORAL SOLUTION DROPS in other countries
The best alternatives with the same active ingredient and therapeutic effect.
Alternative to GLUTAFERRO 170 mg/ml ORAL SOLUTION DROPS in Poland
Online doctors for GLUTAFERRO 170 mg/ml ORAL SOLUTION DROPS
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for GLUTAFERRO 170 mg/ml ORAL SOLUTION DROPS – subject to medical assessment and local rules.
Get updates and exclusive offers
Be the first to know about new services, marketplace updates, and subscriber-only promos.
